• gmp-verlag.de
  • GMP Compliance Adviser Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

2017 - The GMP Regulations Report

Have you considered all last years new regulations?

Make sure you did not miss out on one or the other with our overview of 24 important GMP documents published in 2017.


>>> Read now:
2017-Regulations-Report.pdf

GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

Award for the
GMP Compliance Adviser

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".


TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.


2. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.


3. GDP Audit Questionnaire
More than 700 questions with reference to regulations.


4. A Pharma Guide to Cleaning Validation
How to meet Agency Expectations and Establish Accepted Limits.


5. Data Integrity in the EU
Requirements for Quality Management Systems.


>>> More Downloads

News about GMP/cGMP

2018-03-13

Will the UK Be Part of EMA After Brexit? –EC and UK Follow Different Approaches

While Theresa May promoted the benefits of the UK becoming an associate member of the EMA, the EU took quite an opposite position. In a draft guideline published on 7 March 2018 the EU sets out how the EU council sees its future with the UK. A comment by the British newspaper “The Guardian” states that while the British government does Brexit by speeches the EU prefers releasing documents.

 

The UK biopharma industry supported May in her intention to further remain under the lead of the European Medicines Agency (EMA). She asked the EU for not getting the UK into trouble by moving it into trade models that are designed for much more distant and smaller countries.

And the EU?
The draft guideline reaffirms that being outside of the union could never be as good and profitable as being a member:

The European Council further reiterates that the Union will preserve its autonomy as regards its decision-making, which excludes participation of the United Kingdom as a third-country to EU institutions, agencies or bodies” and the anticipated free trade agreement between the UK and EU “cannot offer the same benefits as membership and cannot amount to participation in the single market or parts thereof.

This means that moving goods across the EU-UK-border will definitely become harder. The European Council recalls that the four freedoms of the Single Market are indivisible and that there can be no “cherry picking” through participation based on a sector-by-sector approach, that would undermine the integrity and proper functioning of the Single Market.

The Council strengthens its position in an explicit way: One possibility for the UK is to join Norway and other countries as a non-EU member of EMA. But if the UK decides to leave the single market and take the power to “decide not to accept” EMA rules, it is clear that those desires are incompatible with EMA membership.

What happens next?
As complete trade talks will begin on UK’s final leave of the EU in March 2019, the final trade deal might take its time. This latest document also contains the EU’s well-known warning “Nothing is agreed until everything is agreed” which means that until a finalized divorce, no progress in trade talks will be made.

A final version of the 6-page-guideline will be discussed at the summit of European leaders by the end of March.

Source:

EU Council: EU draft guideline

The Guardian

Comments
No comment has yet been written about this news.
 
 
Literature recommendation
GMP Compliance Adviser
Single User Licence (yearly subscription)